Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
487 questions in 49 reviews · Breast Cancer
current versionsNo studies 44 · 9%Ungraded 14 · 2.9%Very low 108 · 22.2%Low 128 · 26.3%Moderate 107 · 22%High 86 · 17.7%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Shared decision‐making (all components) vs control Satisfaction with the decision‐making process · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Knowledge of all the options · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | 5 studies · 2114 participants | Low |
Some components of shared decision‐making, including clarification of values and preferences, vs control Adherence to the chosen option · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Choice of an option aligned with each woman’s values and preferences · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Woman's involvement · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Mental health outcomes · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | MD 0.54 | 2 studies · 749 participants | Low |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Satisfaction with the decision‐making process · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Confidence in the decision made · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | MD 2.89 | 2 studies · 1191 participants | Low |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Knowledge of all the options*** · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | MD 1.14 [0.61, 1.62] | 4 studies · 2510 participants | High |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Adherence to the chosen option · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Choice of an option aligned with each woman’s values and preferences · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Confidence in the decision made · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Woman's involvement · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Mental health outcomes · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | MD 0.33 | 2 studies · 1193 participants | High |
Shared decision‐making (all components) vs control Knowledge of all the options · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | RR 1.18 [0.61, 2.28] | 1 study · 133 participants | Very low |
Shared decision‐making (all components) vs control Adherence to the chosen option · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Choice of an option aligned with each woman’s values and preferences · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Woman's involvement · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Mental health outcomes · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Satisfaction with the decision‐making process · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Confidence in the decision made · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | 4 studies · 1714 participants | Very low |
Cognitive behavioural therapy vs control DepressionHospital Anxiety and Depression Scale (HADS) or Beck Inventory Score (HADS score range from 0 to 21 and Beck Inventory Score range from 0 to 63) · Women with non‐metastatic breast cancer Psychological interventions for women with non‐metastatic breast cancer (2023) · Cochrane | no estimate extracted | 27 studies · 3321 participants | Low |
Cognitive behavioural therapy vs control AnxietyHospital Anxiety Scale, STAI (State‐Trait Anxiety Inventory) · Women with non‐metastatic breast cancer Psychological interventions for women with non‐metastatic breast cancer (2023) · Cochrane | no estimate extracted | 22 studies · 2702 participants | Low |
Cognitive behavioural therapy vs control Mood disturbanceProfile of mood state (higher score indicates more mood disturbance, score range from 0 to 200) · Women with non‐metastatic breast cancer Psychological interventions for women with non‐metastatic breast cancer (2023) · Cochrane | no estimate extracted | 13 studies · 2276 participants | Low |
Cognitive behavioural therapy vs control Quality of lifeSeveral tools were used e.g. EORTC, FACT B, Medical outcomes, QoL Cancer Survivor · Women with non‐metastatic breast cancer Psychological interventions for women with non‐metastatic breast cancer (2023) · Cochrane | no estimate extracted | 20 studies · 1747 participants | Low |
Cognitive behavioural therapy vs control Stress · Women with non‐metastatic breast cancer Psychological interventions for women with non‐metastatic breast cancer (2023) · Cochrane | no estimate extracted | 8 studies · 564 participants | Low |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone False‐positive rate · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.43 [1.37, 1.5] | 1 study · 70825 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone False‐negative rate · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.39 [0.23, 0.66] | 1 study · 354 participants | Moderate |
Mammography in combination with breast ultrasonography vs mammography alone Rate of biopsies · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 2.49 [2.28, 2.72] | 1 study · 72717 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection in women with dense breasts: RCT · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.65 [1, 2.72] | 1 study · 11390 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection in women with dense breasts: cohort studies · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.78 [1.23, 2.56] | 50327 participants | Moderate |
Mammography in combination with breast ultrasonography vs mammography alone Incremental detection of invasive cancers · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.91 [0.67, 1.24] | 1 study · 65 participants | Low |
Mammography in combination with breast ultrasonography vs mammography alone Interval cancer · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.29 [0.08, 1.05] | 1 study · 11390 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone False‐positive rate in women with dense breasts · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.76 [1.58, 1.96] | 1 study · 11312 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone False‐negative rate in women with dense breasts · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.23 [0.07, 0.78] | 1 study · 78 participants | Moderate |
Mammography in combination with breast ultrasonography vs mammography alone Breast cancer mortality · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Biopsy rate in women with dense breasts · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 2.73 [2.24, 3.34] | 1 study · 11390 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection for women with non‐dense breasts: RCT · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.93 [1.01, 3.68] | 1 study · 7823 participants | Moderate |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection for women with non‐dense breasts: cohort studies · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.13 [0.85, 1.49] | 40636 participants | Low |
Mammography in combination with breast ultrasonography vs mammography alone Interval cancer · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.22 [0.05, 1.03] | 1 study · 7823 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone False‐positive rate in women with non‐dense breasts · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.36 [1.18, 1.56] | 1 study · 7771 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone False‐negative rate in women with non‐dense breasts · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.18 [0.04, 0.74] | 1 study · 52 participants | Moderate |
Mammography in combination with breast ultrasonography vs mammography alone Biopsy rate in women with non‐dense breasts · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 2.58 [1.96, 3.4] | 1 study · 7823 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone All‐cause mortality · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection: RCT · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.54 [1.22, 1.94] | 1 study · 72717 participants | High |
Mammography in combination with breast ultrasonography vs mammography alone Incremental cancer detection: cohort studies · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 1.35 [0.92, 1.98] | 83469 participants | Low |
Mammography in combination with breast ultrasonography vs mammography alone Incremental detection of invasive cancers: RCT · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | RR 0.95 [0.82, 1.09] | 1 study · 301 participants | Low |